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Abstract  
Collections of human tissue (biobanks) are thought to be an essential resource for biomedical 
research. Biobanks, have however, been a source of debate in both bioethics and sociology. In 
recent years this theorizing has been supplemented with empirical research, including a 
significant body of qualitative research, into donors’ experiences and attitudes.  To date, this 
literature has not been synthesised. We report the findings of a review of qualitative literature 
regarding the ways in which lay people construct and experience the process of donation to 
biobanks. Our aim was to determine what the qualitative research literature tells us about the 
process of donating to biobanks, and how this can enrich existing insights from quantitative 
research and from theoretical sociology and bioethics. Qualitative research shows that 
donation to biobanks is a complex process shaped by donors’ embeddedness in a number of 
social contexts; by complex relations of trust in biomedicine; and by the ambiguous status of 
human tissue. While these findings are theoretically and practically useful, current sociological 
theorizing is very general. A more detailed and nuanced ‘sociology of biobanking’ is needed, 
and this might be best achieved by exploring specific theoretical questions in a variety of 
biobanking settings. 
 
Background and rationale 
 
Background 
In recent years, the focus of biomedical research has shifted from individual bodies and physical 
entities to studies based on networks of data and collections of tissue (Sleeboom-Faulkner 
2009). Stored collections of normal and diseased human tissue (‘biobanks’) have therefore 
become an essential resource for medical research (‘biobanking research’) (Korn 1996). The 
blood, tissue (e.g. connective tissue), parts of organs or whole organs (referred to broadly as 
‘tissue’) that make up biobanks may be removed from healthy donors, from patients in the 
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course of medical diagnosis or therapy, or during postmortem examinations. This provides a 
means by which characteristics of interest, such as anatomico-pathological abnormalities or 
genetic types (polymorphisims), can be correlated with disease aetiology, prognosis and 
treatment responsiveness.  
Theorisations of biobanking 
Over the past decade, a large literature, both theoretical and empirical, has emerged around 
biobanking. Theoretical discussions of biobanking frequently take the form of ethical debates, 
many of which focus on the means of obtaining consent for the long-term storage and use of 
tissues, the management of donor (genetic) privacy, and the commercialisation and ownership 
of the tissue and the products of tissue-based research (e.g. Furness 2004, Savulescu 2002, van 
Diest and Savulescu 2002). Ethical disagreements frequently centre around the tension 
between individual autonomy and the ‘common good’—a tension which is seen to have 
particular salience in the context of biobanking because of the dependence of researchers upon 
entire communities (including healthy populations), many of whom are unlikely to benefit from 
the results of the research. Concern for donor autonomy has, however, recently been qualified 
somewhat by the recognition that autonomy is relational and that trust, solidarity and 
community should be taken into account when thinking about the ethical problems of 
biobanking and their possible solutions (e.g. Barr 2004, Hansson et al. 2006, Hoeyer and Lynöe 
2006, Lipworth et al. 2006, van Diest and Savulescu 2002). 
Sociologists have recognised that biobanks are political entities, created and maintained 
through numerous acts of policymaking and persuasion (Fletcher 2004). Much of the 
sociological literature has, therefore, focused on organisational and governmental motivations 
for establishing biobanks and the complex relationships between government, academic and 
commercial organizations, while critiques of the social organization of biobanks have tended to 
focus on the problems associated with the late-capitalist commodification or ‘marketisation’ of 
the human body and the formation of tissue-based economies, including potential effects on 
the sanctity of the body, human psychological development, dignity, wellbeing, agency and 
kinship. Such views of biobanking tend to translate into efforts to regulate science so as to 
reduce such commercially-driven opportunism and exploitation (Hoeyer 2007, Sharp 2007, 
Waldby and Mitchell 2006).  
Attempts have also been made to theorise the actions and motivations of donors, many by 
reference to Titmuss’s (1970) account of blood donation in Britain in the 1960s in terms of the 
‘gift’ and ‘gift relationship’ (Titmuss 1970). With respect to donors’ motivations, concern has 
been raised about the ways in which donors’ have learned to objectify and accept the removal 
of parts of their bodies to serve (more affluent) others (Scheper-Hughes 2001), as well as on the 
costs for individuals and the community of the public’s often unrealistic expectations of 
potential benefits (Petersen 2009). The latter are seen to stem, at least in part, from the 
tendency of government policies to utilise emotive language, such as the language of ‘public 
participation’, ‘altruism’ and the ‘gift’ in order to promote tissue donation (Tutton 2004). 
Recognition that donors may not be adequately informed and are potentially subject to 
manipulation has led some theorists to question traditional individualistic approaches to 
informed consent, and to emphasise the importance of community consultation and public 
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control of biobank resources (i.e. ‘scientific citizenship’) (Kaye 2004, Weldon 2004), thus 
creating a nexus between bioethical and sociological critiques. 
Empirical research into biobanking 
While biobanking has been the subject of theoretical examination in both sociology and moral 
philosophy, over the past five years research into biobanking has taken an empirical turn. The 
justification for such studies has been that ethical and sociological theorizing is too far removed 
from social reality and that empirical ethics and sociology are crucial adjuncts to theoretical 
work (Kon 2009). Many of the empirical studies of biobanking have been quantitative, often in 
the form of large-scale surveys. Such surveys have been conducted with many ‘biobank 
populations’ including; contributors to twin registries (Toccaceli et al. 2009), biobanks in 
general practice (Treweek et al. 2009), obstetric and paediatric biobanks (e.g. Joseph et al. 
2008, Neidich et al. 2008), and large-scale population gene biobanks (e.g. Kettis-Lindblad et al. 
2006).  
To a large extent, these surveys have done what surveys do best; that is, they provide statistical 
correlations between such things as participation rates and various demographic factors such as 
education, age, gender, socio-economic status, family history of disease and so forth (e.g. Chen 
et al. 2005, Joseph et al. 2008, Kettis-Lindblad et al. 2006, McQuillan et al. 2003). But these 
surveys have also provided an insight into donor understandings, values and experiences. While 
no formal meta-analyses of biobanking surveys have been conducted, some patterns have 
emerged from the published quantitiative data on biobanks. First, there is a generally high level 
of public understanding of, and support for biobanking and a willingness to contribute to 
biobanks (e.g. Kettis-Lindblad et al. 2006, Nilstun and Hermerén 2006, Toccaceli et al. 2009). 
This support appears to derive from a number of motivating factors including altruism, 
‘pragmatism’ (i.e. a desire to contribute to research advancements as part of a balanced 
relationship between participants and researchers) and personal benefit through, for example, 
access to research data (e.g. Joseph et al. 2008, Kettis-Lindblad et al. 2006, Neidich et al. 2008, 
Toccaceli et al. 2009).  
While most surveys suggest that people want to be asked for consent to the storage and use of 
their tissue, there is a general willingness to give open-ended consent (e.g. Kaphingst et al. 
2006). At the same time, however, there are concerns, particularly about confidentiality, 
genetic discrimination and potential misuses of tissue (e.g. for eugenic research)  (e.g. People 
Science and Policy Ltd 2002), and there  is an expectation that access to, and uses of, tissue is 
transparent and controlled by institutional ethics committees, which are generally more highly 
trusted than, for example, political or commercial organizations (e.g. Chen et al. 2005, Joseph et 
al. 2008, Kettis-Lindblad et al. 2006, Treweek et al. 2009). In this regard, several surveys have 
demonstrated that the public is not a priori against commercial access to tissue, and that 
concerns about commercialization, while present, do not generally preclude participation, 
particularly if benefits will be publicly shared (e.g. Jack and Womack 2003, Stegmayr and 
Asplund 2002, Treweek et al. 2009). 
While these quantitative studies have generated important data, there is widespread 
acknowledgment of the limitations of ‘closed’ response categories for questions surrounding 
donors’ attitudes and experiences (Toccaceli et al. 2009) and of the need for a deeper and more 
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nuanced understanding of donor values which can best be achieved using qualitative methods 
(e.g. Dixon-Woods et al. 2008). This is in keeping with the more general recognition within 
empirical bioethics and sociology that qualitative research is important because it provides the 
richness and detail necessary for the development of a nuanced understanding of social 
phenomena (Mason 2002).  
While qualitative research has the potential to challenge theoretical assumptions and assist 
with policymaking, it can be difficult for theorists and policymakers to access and make use of 
this information since studies tend to be published in isolation, making reference to only a 
selected sample of similar studies. Moreover, isolated studies preclude the drawing of higher-
level theoretical and practical conclusions from existing studies. We set out, therefore, to 
systematically review the published qualitative research on lay conceptualisations of 
biobanking and the donation process with the aims of: 1) determining what the qualitative 
research literature tells us about how lay people construct and experience donation to 
biobanks, and what this adds to existing quantitative research, 2) synthesising this information 
in order to generate higher level theoretical and practical conclusions, 3) making this 
information accessible and useful to theorists and policymakers and 4) identifying any gaps in 
existing knowledge where further research is needed. 
 
Method 
Data collection 
In late 2009 and early 2010 we undertook a search of Medline, PsycINFO, and Sociological 
Abstracts databases using the search terms ‘biobank’, ‘tissue bank’, ‘tumo(u)r bank’, ‘gene 
bank’, ‘organ bank’, ‘DNA bank’ (and other synonyms of ‘bank’ such as ‘collection’, ‘repository’, 
‘database’ and ‘retention’). These terms were combined with terms relevant to a number of 
qualitative methodologies (such as ‘grounded theory’, ‘ethnography’, ‘case study’, and 
‘narrative’) and common qualitative data collection techniques (such as ‘interview’, ‘focus 
group’). The search was undertaken in two stages: 1) initial database search 2) secondary 
search of the reference lists of papers identified in stage 1. Since biobanking has only recently 
emerged as a topic of interest, no time limit was placed on the search and we used the origins 
of the databases as our date limits. As proposed by Sandelowski and Barroso, our aim was to 
recall as many papers as possible (that is, we sought sensitivity more than specificity), and to 
this end we employed a dynamic and iterative searching strategy, following leads to maximise 
the inclusiveness of our search (Sandelowski and Barroso 2007).  
A study was included if:  
 at least some of the study participants were lay people, with lay people defined as 
anyone who was not a healthcare professional, researcher or policymaker; 
 the aim of the published study was (at least in part) to explore how/what lay people 
thought about biobanking and the process of donation. We therefore excluded 
discourse analyses of policy documents and studies of professional perspectives even 
though they were qualitative.  
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 the data collection and analysis method were reported as qualitative by the authors. 
 
We excluded studies about biobanks that were established for educational or therapeutic 
(rather than research) purposes (e.g. blood banks, bone marrow banks, bone banks, cornea 
banks). We also excluded studies of collections of reproductive tissue (gametes, embryos) since 
the scientific, ethical and legal issues raised by these kinds of biobanks are distinct and we 
excluded collections of tissue intended only for genealogical research. We also excluded reports 
of research that had not been published in the academic literature. We identified 36 relevant 
articles published between 2002 and 2009 (see Table 1-Refer to pages 25 onwards).  
 
Appraisal 
All papers were independently reviewed and analysed by two authors (WL and RF). Excluding 
papers on the basis of methodological quality was made difficult by a frequent lack of detail in 
reporting methods and methodology, and we faced the well-recognised epistemological 
challenges in attempting to define quality criteria and critically compare different qualitative 
methodologies (Kuper et al. 2008). As our aim was to find maximum variability and make a 
useful interpretation of the literature, rather than to identify the ‘best’ publications on the 
topic or carry out a formal meta-synthesis of one particular question, we decided, as Thomas 
and Harden and others have done (Atkins et al. 2008, Thomas and Harden 2008), to include all 
articles that were deemed worthy of publication in peer-reviewed journals or edited collections 
of papers.  
 
Research questions and data analysis 
Qualitative studies were treated as primary data sources. In reading each study, we asked the 
following open-ended questions: 
1) How do the authors justify their methodology? 
2) What does the study tell us about the ways in which lay people conceptualise and experience 
biobanking and the process of donation?  What does this add to survey research? 
3) What theoretical (ethical and/or sociological) and practical conclusions do the authors draw 
from their results? 
 
A note on data presentation 
The referencing system used in the results section is different from the introduction and 
discussion in that article citations are numbered according to their alphabetical order in 
Supplementary Table 1. A full citation for each may be found in Table 1. This form of 
referencing is aimed to facilitate rapid reference to the table so as to contextualise the authors’ 
arguments and findings.  
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Results 
Characteristics of studies 
A total of 36 qualitative studies were included. In most studies, sampling was purposive and 
aimed at maximal variation rather than population representativeness. Populations studied 
included people who had previously donated tissue for research, people who were in the 
process of considering donation and people who had never before been asked to donate or 
considered the issues surrounding biobanking. In some cases, donor proxies were studied, such 
as parents, who were asked to discuss their decision to donate their children’s tissue and family 
members who were asked to discuss their reactions to non-consensual post-mortem organ 
retention. Qualitative studies examined the full range of biobanking practices. Tissue types 
included collections of blood from healthy donors, collections of diseased tissue (especially 
tumours) removed during the course of diagnosis or treatment, and collections of tissue 
removed during postmortem examination. Some of the biobanks studied were earmarked for 
research into specific diseases (or groups of diseases), while others had broad and open-ended 
research briefs (the latter was particularly the case for population biobanks). In keeping with 
the variety of biobanks studied, donor populations of interest included entire populations of 
countries or geographical regions (population biobanks), people with a particular disease 
and/or risk factor, and people with particular demographic characteristics.  
Research methods most commonly involved semi-structured interviews and/or focus groups 
with a few studies performing ethnographic observation of public deliberations or consent 
procedures. As discussed above, few papers went into detail about their methodological, 
epistemological or ontological assumptions. Data analysis was most commonly described as 
inductive and thematic and used one or another variant of constant comparison to develop and 
analyse themes. Research questions were usually open-ended, with the aim of examining some 
combination of donors’ attitudes, experiences, and justifications for participation or refusal to 
take part in specific kinds of biobanking. 
 
Table 1 (pages 25 onwards) summarises the characteristics of included studies.  
 
Justifications for the research 
 
Justifications given for studying biobanking as a topic were fairly uniform, irrespective of the 
authors’ discipline (bioethics, sociology, anthropology, public health, pathology, etc). General 
arguments for exploring the topic included the importance of biobanks as scientific resources, 
particularly in the context of advances in genomics and ‘personalised medicine’, as well as the 
need to pay attention to an area that has been relatively neglected within research and public 
health ethics, in which obvious historical abuses have occurred and in which social criticism and 
legal scrutiny seem to be rapidly increasing [1,3,4,7,11].  
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Justifications given for studying the topic empirically were also fairly uniform. The most 
common justification was the need to take seriously the ethos of ‘public engagement’ 
‘community consultation’ and ‘deliberative democracy’ so as to identify and explore any 
disjunctions between public opinion and current biomedical practices, laws and policies and to 
include public views in policy debates and legal resolutions [5,8,12,22,25,31,34]. Another 
common justification was the need to explore differences among subsets of lay populations and 
to compare the perspectives of the lay public and biomedical or bioscientific professionals 
[1,8,13,22]. More generally, it was argued that there is a need to modulate the ‘activist’ 
tendencies of those who have begun ‘speaking for’ those who contribute tissue for research 
purposes, and that we need to avoid making assumptions about public views on the basis of 
isolated incidents or regulatory trends [5,33]. More specific justifications for empirical research 
into biobanking included the need to empirically explore public attitudes towards consent,  
personal benefits, feedback of results, commercialisation and donor privacy 
[1,2,3,4,7,9,13,26,27,32]. 
  
A number of scholars emphasised the problems associated with discussions of biobanking that 
are dominated by abstract theories and disconnected from ‘real-world’ insights. Organising 
concepts, such as ‘gift’ and ‘participation’—concepts that are often taken for granted in 
theoretical discussions of organ and tissue donation—were seen as worthy of empirical 
investigation [2,4]. Trust and perceptions of risk were also seen as issues demanding detailed 
empirical interrogation—including taking a ‘practical view’ of trust with a focus on the sorts of 
evidence that people require in order to place their trust well [23], and considering the 
possibility that tissue donors might have complex relationships with risk than are evident in 
typical arguments about the ‘risk society’ [4].  Along similar lines, it was noted that notions of 
‘benefit’ also demand empirical exploration, given that there is likely to be cultural variation 
around what benefits are (e.g. monetary benefits, health benefits) and how they can be 
delivered—expectations that are, in turn, closely linked to the promises that are made by 
scientists [12].  
 
A number of researchers also spoke of the need to empirically interrogate bioethical analytical 
frameworks [4,14,17,18]. More specifically, several authors noted that ‘biobanking ethics’ is a 
power-laden and socially constituted discourse that needs to be situated and analysed in its 
socio-historical context and that there was a need to pay attention to ‘ethicality’—the situated, 
specific and experiential ethics talk of citizens embedded within socially and historically 
constituted life-worlds [4,9,14,17,18,30]. And even where bioethical frameworks were seen to 
be appropriate, it was recognised that empirical research is needed for bioethical principles to 
be put into practice so that the maximum good can be done while minimising infringements of 
autonomy, integrity and justice [9].  
 
While few authors made a clear distinction between the need for qualitative or quantitative 
research, there was recognition that qualitative research was needed in order to explore the 
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context of answers to survey questions [23]; to explain apparent paradoxes (such as surveys 
showing high levels of concern in the context of almost universal agreement to donate) [13]); to 
open up the ‘black box’ of donor decision-making [13,16] and to explore the various ‘subject-
positions’ that people assume in the course of a discussion about biobanking [35]. More 
generally, it was argued that in-depth qualitative inquiry was needed in order to display 
ethnographic sensitivity towards the dilemmas and values of social agents—i.e. to explore the 
‘social life of moral concerns’ [18,19].  
 
 
Key findings of qualitative studies 
1. Qualitative findings that confirm, refine and qualify the results of surveys 
To some extent, the findings of qualitative studies—particularly those that were not 
theoretically oriented—simply confirmed, qualified and refined the results of surveys. Given 
space limitations, these findings are summarised briefly here. 
Knowledge of, and support for biobanking 
In keeping with the findings of surveys, lay people generally appeared to have a good 
understanding of the basic principles of biobanking research and the capacity to understand 
information provided to them [3,11,22,28,29].  Qualitative research also showed that the lay 
public was generally supportive of biobanking, optimistic about its potential, and willing to 
participate [7, 8,9,31 34]. Qualitative studies also confirmed survey findings by suggesting that 
people had many reasons for donating to biobanks, including altruism [4,7,8,9,10,19,24,27,28], 
reciprocity [2,5,10,24,27], and the expectation of personal benefit through new therapies 
[2,9,11,27,28], direct feedback of study results [4,8,9,21,22], the clinical encounter surrounding 
donation (e.g. a test or physical examination) or monetary compensation [10,22,25,28]. At the 
same time, others justified their participation on the basis that they simply did not mind 
donating, particularly when there was so little (perceived) cost or risk involved as compared, for 
example, to participation in clinical trials [4,13,14].  
 
Concerns about biobanking 
For the most part qualitative studies corroborated survey findings showing that people 
recognised at least some potential risks associated with biobanking. The major concern to 
emerge inductively from qualitative research was the potential for breach of data security and 
release of personal (genetic) information to third parties including the police, insurance 
companies and employers, with resulting stigma and discrimination 
[3,8,9,11,21,22,23,25,27,31,35]. But concerns about confidentiality were qualified: many did 
not consider information to be sensitive or delicate, and privacy concerns did not always 
emerge as  
 9 
a dominant theme in interviews and focus groups [9,28,34]. Indeed, some lay people expressed 
concern that excessive focus on donor privacy might impede medical research [21,31]. Also, as 
will be discussed below, few expected to come to harm as a result of their participation. 
 
Specific preferences regarding the governance of biobanks 
As has been reported in many surveys, most qualitative studies have found that, while people 
had concerns about consent procedures [11,25,28,31]), most people wanted to be asked, at 
least initially, about use of their tissue in research and wanted to be told whether the tissue 
would be accessed in future for different research purposes, including commercial research 
[1,5,8,11,13,22,31,33]. But while people wished to be asked for permission to store their tissue 
sample, they did not necessarily want large amounts of detailed information about the biobank 
[2,6,16,18,19,32,35]. Indeed, observations and discussions of consent processes showed that, 
while people wanted to be asked, they did not seem particularly interested in the information 
they were offered during the consent process [6,16,18,19]. Furthermore, few people demanded 
recurrent, project-specific consent and few wished to place limits on the uses to which their 
tissue could be put [3,19,31]. In contrast, there were mixed views as to whether people should 
be able to withdraw their tissue [3,21,22,31].  
With respect to the feedback of information, there was a widespread expectation that, as a fair 
exchange for participation, donors should be given general feedback on the progress of the 
research and provided with aggregated results [1,3,8,9,11,21,27,28].  In contrast, whether 
donors should be given personal results that may have clinical implications for them or for their 
families was a source of much greater disagreement among lay donors [2,3,7,9,11,21,22,26,27, 
28]. 
When asked to think about access to biobank resources, people generally had little concern 
about publicly-funded academic researchers accessing their tissue and personal information 
[3,11,24,28]. Slightly greater concern surrounded access by non-academic, government-funded 
researchers [3,11] while most concern surrounded access by commercial researchers. Few 
studies, however, found that donors believed that commercial researchers or entities should be 
completely prohibited from accessing public biobanks, provided that the benefits of their 
research would be shared [3,4,8,11,12,15,18,23,24,28,30,34]. And, notwithstanding theoretical 
sociological concerns about commercial exploitation of tissue donors, very few people 
expressed an interest in owning their tissue or benefiting financially from the outcomes of the 
research [1,11,12,18].  
Importantly, qualitative studies also made it clear that there is a public expectation that all 
biobanks—whether public or private—should have in place formal mechanisms (including 
institutional review committees and public consultation) for controlling biobank resources and 
for ensuring that research is appropriate and that benefits of research are shared 
[7,11,12,18,23,24,31,35]. Finally, it was recognised that whatever group was ultimately 
responsible for the establishment or functioning of a biobank, this group needed to be legally 
accountable as well as open, empathic and responsive to donors’ and the general public’s 
concerns about the ways in which biobanks were being administered or utilised [8,11,33].  
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2. Qualitative findings that contribute new insights to ethical and sociological theory 
While qualitative research provided useful confirmation and refinement of quantitative studies 
into biobanks, the great strength of these qualitative studies lay in their capacity to enrich 
sociological theory. Observations of particular theoretical relevance included the findings that: 
1) Donation always occurs in a social context; 
2) People are aware of the potential risks of biobanking, but usually do not expect to be 
harmed; 
3) People do not always consider tissue to be ‘sacred’ or a part of their identity. 
 
The social context of donation 
Qualitative research demonstrated that donations are always socially situated and that the 
decision to donate is a relational activity, whether locally, civically or societally. People could, 
for example, experience pressure to donate from family members or as a result of their respect 
or liking for a particular clinician or researcher [2,4,9,10,22,36]. In this regard it is worth noting 
that people generally appeared to understand the necessity for clinicians to sometimes assume 
dual roles as both an ‘instrument of care’ and a recruiter for research [2]. Qualitative studies 
also found that perceived membership of a disease community or an ethnic community could 
have a powerful influence on the decision to donate, as people considered themselves to be 
united by a sense of common purpose, in which values and interests were shared and members 
of the community were to be trusted [5,27]. Finally, qualitative research demonstrated that 
people could also be motivated by a broader sense of citizenship to contribute to population 
level biobanks, although this motivation appeared to be strongly contextual (e.g. such 
expressions were most common in welfare states with public health systems) [16,19,35]. 
 
The importance of trust in modulating perceived risk 
In addition to elucidating the specific concerns that people had about biobanks and about 
biobanking research, qualitative studies provided an explanation for the apparent paradox, 
evident from quantitative studies, that there is no simple linear association between perception 
of risk and (un)willingness to donate. First, as described above, qualitative research 
demonstrated that people were willing to subject themselves to risk because of a commitment 
to scientific progress, reciprocity or the expectation of personal benefit. Second, qualitative 
studies repeatedly demonstrated that, while aware of the potential risks of biobanks, people 
generally had a high level of trust in biomedical researchers and research institutions and did 
not expect to come to harm. Indeed, in some studies, recognition of potential risks of donating 
to biobanks emerged only after persistent enquiry [3,11,21,24,27,32].  
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In some studies, people explicitly described having high levels of trust in biobanking 
researchers, while, in other studies, expressions of trust were less direct, but suggested by a 
belief that scientists would stay true to their promises, in the sense of both generating new 
epidemiological insights into disease and treatment [4,5,11,21,27,32,34] and complying with 
ethical and legal guidelines and taking steps to avoid causing harm [3,25,27]. Trust was also 
evident in the finding (discussed above) that people did not demand recurrent, project-specific 
consent, excessively rigid regulation or complete control over the uses of their tissue.  
 
The trust that donors or potential donors had in biobanking researchers appeared to be based 
on either an explicit assessment of the risks and benefits of biobanking and the trustworthiness 
of researchers or a relatively unreflective ‘faith’ in researchers or the scientific endeavour 
[4,5,25]. Where people were able to explicitly articulate the basis of their trust, it was clear that 
their expectation of protection stemmed largely from the reassurance that they felt from 
biobanks being embedded in public research institutions with oversight processes [5,21,24,31]. 
(Interestingly, individual scientists were sometimes viewed as less trustworthy than the public 
organizations in which they carry out their research [1,4,24]). Indeed, it was clear that trust 
stemmed largely from the expectation of some form of public oversight and control of the 
biobank, either through institutions or legal and health systems as a whole [18,34].  
 
Finally, the salience of trust was evident in the fact that, in the relatively rare cases in which 
people did refuse to donate, they did so not so much because of the potential risks of donation, 
but because protection of donors could not be assumed or assured [2,3,9,11,14,20,25,33]. Not 
surprisingly, trust was found to be low among indigenous groups [30] and in populations whose 
trust had previously been breached (e.g. parents whose children’s organs had been retained 
without consent) [33]. Instances of overt mistrust of biobanks and biobanking researchers 
were, however, extremely uncommon, suggesting that, despite the ‘scandals’ that form such a 
large part of the ethical and sociological literature on tissue donation, trust in the entities 
carrying out biobanking research is often high and stable.  
 
The status of tissue and personal information 
 
The third observation of theoretical relevance was that most lay donors did not seem to be 
deeply concerned about personal ‘defilement’ or loss of identity because tissue was ‘sacred’ or 
intrinsic to the self. Indeed, diseased tissue (such as tumour samples) was often seen as a 
completely foreign and unwelcome invader,  while other types of tissue, such as placental 
tissue, were seen as ‘waste material’ of no particular significance (except perhaps to specific 
cultural groups) [2,5]. Interestingly, even DNA was not always seen to hold particular value 
except insofar as it could be misused, leading to discrimination [4,23]. In this regard, it was 
noteworthy that some people attached more significance to personal information than to 
tissue samples (although it is not clear to what extent this stemmed from a poor understanding 
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that tissue can be a source of personal information) [2,9,15,18,19]. Such findings do, however, 
need to be qualified by the fact that most qualitative studies have been conducted in Western 
or Westernised populations, and not in indigenous or migrant communities where tissue might 
hold a greater significance [29]. Moreover, qualitative research has shown that even in Western 
populations, different kinds of tissue (e.g. whole organs) hold more value than other tissues 
and the value attached to tissue could change over time and differ in different contexts 
[1,5,33]. Interestingly, the qualitative interview itself sometimes made donors more cognisant 
of the significance of their tissue, as they learned more about the potential risks and benefits of 
biobanking research [17]. 
 
Theoretical and practical conclusions drawn from the studies 
 
In addition to being interested in the results of qualitative studies of biobanking, we were also 
interested in the more abstract theoretical and practical conclusions drawn by qualitative 
researchers, with a view to comparing these with a priori theoretical and policy discussions of 
biobanking. In this regard, a key finding was that the majority of authors of qualitative studies 
did not reflect theoretically on their findings, and those who did focused on a similar—albeit 
differently expressed—range of theoretical issues and came to similar practical conclusions.  
 
Authors’ reflections on the social context of donation 
 
A number of authors attempted to make theoretical sense of the social context of donation,  
Haimes and Whong-Barr [13,14] argued that it is better to use the word ‘participation’ than 
‘donation’ to reflect what is a highly social process with multiple meanings [13,14]. They argued 
that it is too simplistic to think of there being just two groups: donors and non-donors. Rather, 
there are varying levels of donation and non-donation and there are different ways that 
individuals donate or do not donate. Whether or not people agree to donate, they are 
constructing themselves as ‘ethical beings’ and trying to demonstrate that they are ‘being 
ethical’, however this might be defined in the specific context in which the act of donation is 
taking place. 
 
Drawing on Haimes and Whong-Barr’s ideas, Hoeyer and colleagues argued that the 
intersubjective ‘transaction’ that occurs when blood or tissue is donated in the clinical setting 
needs to be viewed as a moral negotiation between a donor and a health care practitioner 
[16,17,19]. This, they argued, might explain why donors lack interest in the consent form, 
because in the clinic, people adopt practiced roles in which they enjoy the care of health 
professional and wish to transfer responsibility for decision-making to the medical profession 
and to the state. And while this may appear passive, it remains an expression of embodied 
agency and ethical communication (as well as perhaps an act of resistance to an imposed sense 
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of responsibility for the outcomes of research). The act, therefore, has ‘intersubjective texture’ 
in that, the ‘personhood’ involved in making the decision is a transitory ‘we’, not an 
autonomous ‘I’. To explain why donors may still wish to be asked for permission to store tissue 
even if they have little interest in consent forms, Hoeyer and colleagues drew upon the 
Foucaltian  idea of ‘practices of the self’ (Rabinow 1997), according to which it ‘feels right’ to be 
given a choice and to present oneself as a responsible actor, without the implications of the 
choice and responsibility necessarily being considered in depth. They concluded that, when 
understood this way, we can recognise that apparently uninterested individuals are also 
responsible actors, but that their concern is more with public oversight and knowledge than 
with informed consent. 
 
Haddow [10] focused on the familial context of some donations, concentrating her gaze on the 
finding that familial recruiting is often carried out by women. She concluded that, despite the 
rhetoric of fluidity in sociological theorising of the family, in biobanking research there remain 
traditional expectations of female responsibility for maintaining family relationships. Her work 
also examined the way in which people participate in biobanking for the good of future 
generations, arguing that there is a temporality embodied in biobank participation, which 
acknowledges the impact of the past on the present (though the conduit of presumed biological 
connectivity) but looks to the future in order to maintain a family lineage that avoids biological 
harm.  
 
Other research emphasised the importance of the norm of reciprocity in motivating people to 
donate. Hoeyer, for example, [16] noted that this norm is likely to have particular salience in 
welfare states (such as Sweden) which emphasise self-discipline, solidarity, trust in science, 
right and duties, and in which patients combine their personal health projects with a wish to 
respond to societal efforts undertaken on their behalf. Combining several theoretical concepts, 
Hoeyer suggested that donation is an act in which the donor not only wishes to reciprocate for 
what he/she has received in the past, but also attempts to convey the wish that the rest of the 
world will feel obliged to do the same. According to this view, the donation of blood and the 
messages conveyed at the interview can be seen as symbolic exchanges emphasising a 
commitment to honesty and a shared future. Linking this to donation as an act carried out by 
an individual within an intersubjective context (discussed above), Hoeyer pointed out that the 
webs of mutual obligation that create a sense of societal duty are part of a personal frame of 
experience (including previous encounters with the system), personal hopes and objectives 
(e.g. a health examination); and direct intersubjective negotiation. Reflecting once again on 
donors’ lack of interest in consent forms, Hoeyer suggested that this might be a manifestation 
of a valid desire to trust the logic of mutual obligations embedded in the state-citizen 
relationship, in which authorities, rather than patients, take responsibility for scientific 
enterprises [18]. 
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Viewing societal solidarity from another angle, several authors focused on the ways in which 
‘public’ and ‘scientific’ worlds overlap in the context of biobanking. Dixon-Woods et al [5] 
argued against the idea of there being a large gap between the social worlds and discourses of 
the ‘public’ and ‘bioscience’ and argued that we should think instead about ‘hybrid social 
worlds’ in which the boundaries of research are porous and in which the agendas of ‘patients’ 
and ‘scientists’ are mutually influential—in part through the exchange of rhetoric and imagery 
relating to research and research materials, as well as the material itself [5]. Haddow et al [11], 
came to a similar conclusion, arguing that similarities in attitudes between public and 
professionals regarding a population biobank are indicative of ‘non-codified knowledge’ 
crystallising around a shared area of relevance and that there is a common stock of knowledge 
to be drawn upon in discussions about ethical, legal and social issues such as biobanking [11]. In 
this regard it is noteworthy that they and others suggested that the supposed lay-expert 
knowledge divide exists not so much between the public and scientists, but between the public 
and ethicists and other ‘advocates’ who attempt to speak on their behalf [5,11,33,34]. 
 
Recognition of the importance of social exchange led several authors to suggest that more 
attention needs to be paid to ways in which this social system (which is based on both trust and 
solidarity) can be sustained, including providing donors with tangible benefits (e.g. health 
checks, or feedback of results) and focusing  on the ways in which society organises and 
structures its health and welfare systems so as to ensure that everyone benefits equally from 
biobanking research (particularly in the context of commercialisation) [4,12,24]. Given the 
emphasis on the commodification of the body in recent decades, it is noteworthy that no 
authors argued for the establishment of new property rights and it was argued that property-
based approaches would obscure the need to focus on the public and communal nature of 
research and to ensure that benefits are shared equally [12].  
 
Not all authors, however, were equally convinced by findings suggesting a strong 
intersubjective bond or sense of solidarity among donors, researchers and health professionals. 
Rather than speaking of communities bound together through biobanking, a number of 
researchers emphasised the individuality of each donor or donor community and the wide 
variety of ways in which individuals and communities constructed themselves in discussions of 
biobanking. This was framed in a number of ways: donors were seen to be constructing 
themselves as ‘ethical beings’ acting in different, but equally morally acceptable ways [13.14]; 
as adopting different ‘subject positions’ and as drawing on a variety of ‘discursive repertoires’ 
within discourses of participation [35] and as having different ways of constructing their social 
identities [29]. While it was acknowledged that all of these processes take place in the context 
of groups, it was also emphasised that there was little reference to over-arching principles, 
norms or rules about ethical conduct [13,14]. This ‘situated ethicality’ was seen to be 
particularly evident among indigenous communities, the narratives of whom exhibited a critical 
awareness of their situatedness [30].  
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A number of authors also displayed overt scepticism about the extent to which social 
encounters were truly empowering. It was, argued, for example, that in certain intersubjective 
(e.g. clinical) contexts, people may donate (or refuse to donate) fairly unknowingly [4] and that 
a strong intersubjective bond could create a relationship of dependence, which makes refusal 
to donate tantamount to refusal to give a gift, which is to reject the bond of alliance and 
commonality [16]. At the societal level, it was argued that notions such as ‘genetic solidarity’ 
may be overplayed in discussions of research participation, and that the extent of lay people’s 
uncertainty about participation might be obscured by the emphasis in the sociological literature 
on lay knowledge/expertise and by equating motivations to donate tissue for research with 
motivations to donate blood for transfusion [4]. Similarly, others argued that institutional 
discourses of active participation, which draw on the language of active citizenship and 
community involvement, are both ambiguous (in that people remain uncertain and distrustful) 
and ethically problematic (in that they are exemplary of neoliberal governmentality, governing 
individuals through their regulated choices) [35]. Finally, was noted that the degree of solidarity 
is likely to depend upon the political context (e.g. stronger in a welfare state than in an 
individualist society) [16,34] and on the extent to which traditional notions such as the gift 
relationship are being eroded by commercialisation and associated donor expectations of 
benefit [12].   
 
 
Authors’ reflections on trust as a mediator of risk perception 
 
While a small number of authors argued that there are low levels of trust in biobanks and that 
this threatened their viability [8,23], most concluded that there are high levels of trust in 
biobanks and biobank researchers and that this is an important mediator of the decision to 
donate. Indeed, for some authors, this challenges the ‘social unease discourse’ in which actual 
or potential tissue donors are assumed to be either untrusting and suspicious of biomedical 
research [1,3,4,5,6,24].  
 
Two practical conclusions of this work on trust in biobanking feature in the literature. First, 
many authors argue that, given these high levels of (warranted) trust, and donors’ lack of 
interest in formal and recurrent consent processes, consent should not be excessively onerous. 
Thus, while initial consent should be obtained, highly detailed or recurrent, project-specific 
consent should not be imposed unless participants specifically request it [1,2,7,24]. Put another 
way, more consent is not necessarily better consent and it is legitimate for donors to not want 
to be fully informed about biobanking research, but rather to participate in a moral exchange 
characterised by high levels of trust [2,16, 24]. A second, related, practical conclusion is that, 
while trust might be warranted, it cannot be taken for granted since trust is an emergent 
property of good social relationships that are built up over time [23]. Suggestions offered by 
researchers for avoiding ‘doing violence to trust’  [5], included; training researchers to be more 
sensitive to ethical issues; making transparent the identities of researchers and any commercial 
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spin offs of research; allowing people to communicate with researchers (perhaps via health 
professionals) so that their values can be heard and respected; providing feedback on the 
progress and results of the research; and acting with social responsibility in distributing the 
benefits of research  [1,3,5,8,9,19,24,25,26,29]. Institutional arrangements may also build trust 
by focusing on protecting human subjects through independent institutional committees and 
limiting the power given to any one group [2,3,11,19,21,23,24,31].  While it was noted that 
such measures might be enacted spontaneously by biobankers who recognise the preciousness 
and fragility of their ‘warrants of trust’, many authors saw the need for at least some external 
independent oversight of biobanking organisations (including lay representation despite the 
difficulties inherent in such inclusiveness) and strong legislation that is responsive to the 
findings of public consultations [2,511,13,14]. At the same time, however, a number of authors 
cautioned against excessive demands for transparency and external regulation of biobanks, on 
the grounds that this might not necessarily be conducive to trustworthy behaviour, nor a 
guarantee of high levels of public trust [2,11,19,23,24] . 
 
The view that the public trust in biobanks is warranted and that the focus should be on 
maintaining this trust was not, however, an entirely uniform conclusion. A few authors, for 
example, questioned the assumption that trust was reasoned and/or justified, arguing that 
trust may be based on unwarranted faith, deference, manipulation or misunderstanding. In 
other words, a few authors saw trust, and the associated ‘political economy of hope‘ (Novas 
2006) as naive and unwarranted rather than sophisticated and wise. Not surprisingly, these 
authors came to very different practical conclusions regarding the governance of biobanks, 
noting that trust has a complex relationship to informed consent and legislation, and that 
caution is needed when responding to donors’ apparent readiness to transfer their trust to 
scientists and health professionals [4,511].  
 
 
Authors’ reflections on the status of tissue  
 
The third theoretical area that was given attention by authors of qualitative studies was that of 
the ambiguous status of human tissue. Dixon Woods et al [5] argued that tissue samples 
donated to biobanks are ‘boundary objects’ which can be recognised simultaneously as ‘waste’ 
and as precious work objects—precious in the sense that they promote in donors a sense of 
being embedded in a community of ‘biological citizens‘ (Rose and Novas 2005). Hoeyer [17] 
used the ambiguous status of tissue to explain how people who profess to not be interested in 
consent forms become somewhat anxious when asked to discuss donation in the context of a 
qualitative interview. He concluded that, in the context of a clinical encounter, the blood that is 
donated is ‘only blood’, but during an interview, in which people are forced to reflect on the 
ways in the blood may be (mis)used, the blood comes to be seen as ‘part of’ the person, 
integral to his or her personhood and agency. In another paper, Hoeyer [15] argued that the 
ambiguous status of tissue (as well as that of personal information) can be understood with 
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reference to the idea of ‘the cultural biography of things’ according to which different meanings 
are ascribed to objects throughout their lifetime. According to this view, human tissue passes 
though different spheres of exchange and can thus be viewed as being ‘beyond trade’ at one 
point and ‘just a commodity’ at another. In the case of biobanking, therefore, donated blood is 
first conceptualised as a substance, as part of the person which is non-tradeable and provided 
as a gift with the expectation of improved health in return, while in the course of 
commercialised research, however, blood may be transformed into information which can be 
patented and sold. 
 
Discussion 
 
General observations 
 
Qualitative enquiry, and theorising from qualitative findings, can  provide a rich and nuanced 
picture of the ways in which people understand, experience and construct the process of 
donating tissue to biobanks. It is clear from qualitative research that donation to biobanks is  
simultaneously intersubjective, familial, communal and societal; is a process involving complex 
relations of trust which powerfully mediate the perception of risk and the desire for personal 
control; and is shaped by the many ambiguous meanings ascribed to human tissues, organs and 
the body more generally. Moreover, in each of these general approaches to biobanking lies a 
great deal of complexity and disagreement among people with slightly different theoretical 
orientations. 
 
A number of general observations of relevance to sociology can be made. First, in the existing 
qualitative literature, many social theories have been used to understand and explain the 
context and process of biobanking research. While not all authors situated their work 
theoretically, those who did made reference to wide variety of social theories and theorists. To 
give a few examples: those attempting to explain people’s general willingness to donate to 
biobanks drew upon theories such as Putnam’s norm of generalised reciprocity (Putnam 2000), 
Titmuss’ and Mauss’ conceptions of gift relationships (Mauss 2000, Titmuss 1970), Rose and 
Novas’ ‘biological citizenship’ (Rose and Novas 2005) and Novas’ ‘political economy of hope’ 
(Novas 2006). To explain why donors might wish to be asked for permission to store tissue, yet 
show little interest in consent forms and resist taking ultimate responsibility for their decisions, 
a number of theories were referred to including Rose’s idea of informed consent as part of a 
biopolitical development (Rose 1999)and Foucault’s ‘practices of the self’ (Rabinow 1997). 
Efforts to account for different styles of participation in biobanks, in the absence of any over-
arching ethical system, were supported by reference once again to Foucault’s ‘practices of the 
self’ (Rabinow 1997) as well as to Giddens’ (Giddens 1991) and Bauman’s (Bauman 1993) 
accounts of the individualistic ‘life politics’ of late modernity. Authors wishing to criticise what 
they perceived to be an excessive focus on consent, and a failure to a account for high levels of 
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public trust, drew upon Power’s critique of an ‘audit society’ (Power 1997), Wolpe’s critique of 
a consumer driven culture in which patients are viewed as customers to be wooed (Wolpe 
1998), and O’Neill’s ideas about the importance of ensuring genuine institutional 
trustworthiness rather than focusing entirely on autonomy and shallow accountability (O'Neill 
2002). Finally, differential and shifting attitudes towards blood, tissue and personal information 
were explained with reference, for example to Star’s idea of ‘boundary objects’ (Star and 
Griesemer 1988) and Mauss’ idea that, human beings (and their body parts) might be viewed as 
subjects only, not to be consumed (Mauss 1985 [1938]). 
  
This variety suggests that there is no single sociological theory or concept that can account for 
the process of donating to biobanks. Rather, any ‘sociology of biobanking’ would need to be 
nuanced and to draw upon a variety of social theories in order to account for the donor 
population (e.g. people with a serious illness vs. healthy donors vs. an ethnic group), the type of 
tissue being donated (e.g. tumour vs. blood vs. DNA) and the context of the donation (e.g. 
recruiting patients in a medical clinic in a welfare state vs. a public drive for a commercially-
owned biobank). 
 
A second general observation is that there is a disjunction between the concerns of tissue 
donors and the concerns of many sociologists, with many academic critiques focusing almost 
exclusively on issues related to tissue ownership, biopower, commodification of the body and 
the formation of tissue-based economies. While lay people do have some concerns about these 
issues, for the most part people are not a priori against commercially-funded research, 
particularly if they can be reassured that the relevant scientific questions will be asked and that 
benefits will be publicly available. Moreover, the results of qualitative studies suggest that few 
people feel a strong sense of ownership of their tissue. And where an expectation of reciprocity 
does emerge (e.g. in the expectation that results will be made available), this appears to be 
based on a generalised reciprocity centred on social exchange rather than on any expectation 
of direct personal (e.g. pecuniary or even non-pecuniary) reward. This is not to suggest that 
such theoretical concerns are unimportant—indeed, qualitative research makes it even clearer 
that such awareness is crucial for ensuring that donors are not exploited and that their 
generosity and trust are warranted—rather, it is important to ensure that these concerns do 
not obscure other issues that are important to tissue donors. 
 
The final general observation is that, despite the apparent theoretical complexity of biobanking, 
qualitative and quantitative studies of donation to biobanks, be they theoretically-
informed/reflective or not, reach remarkably similar conclusions about the governance of 
biobanks. First, there is broad agreement that consent is not a panacea. While potential donors 
should always be asked for their permission in a manner that is sensitive to specific 
vulnerabilities and desires, it is also  generally agreed that people should not be forced to 
absorb large amounts of technical information or to give recurrent, project-specific consent 
unless they so desire. Second, there is also general agreement that rigorous oversight of 
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biobanks is crucial and that this oversight should combine public control and oversight by 
institutional ethical and scientific review committees. Finally, while the practical demands of 
distributive justice are complex and unclear, it is generally agreed that the benefits of 
biobanking research should be shared. In other words, there is general agreement that it is 
important to take seriously the results of research, which consistently reveals high levels of 
trust; a desire for, or expectation of, reciprocity and an expectation of public involvement and 
benefit-sharing. While this convergence at the practical level provides reassurance that such 
practical approaches have a solid empirical basis, it also raises questions about the value of 
detailed sociological theorising in this context (and in the context of technological innovation 
more generally), and whether more practical use can be made of the detailed insights derived 
from sociology. 
 
Future directions 
 
While qualitative research has provided many important insights into biobanking, such research 
is, however, unavoidably limited by the difficulties in drawing generalizations from studies of 
small and disparate groups, and it seems likely that existing qualitative research has largely 
achieved its potential in this regard. We would suggest, therefore, that future qualitative 
research should focus on groups that are currently under-represented and under-served 
(particularly indigenous and migrant communities)—especially given that these populations are 
so often of scientific ‘interest’ and that it is within these groups that issues regarding the 
commodification and the status of tissue are most likely to emerge. We would also argue that 
future research needs to move beyond its current preoccupation with the initial decision to 
donate, and its tendency to focus on people who have not (yet) donated tissue and are thus 
considering the issues only hypothetically. Although this is understandable, as most biobanks 
have been established within the last few years, as time passes, it will become possible—and 
essential—to focus on the ongoing experience of having one’s tissue stored in a biobank, with a 
view to determining whether the findings summarised here retain their salience and 
appropriateness. Finally, we would argue that certain kinds of organ/tissue donation might 
raise unique issues which would warrant further qualitative exploration. The donation of whole 
brains, for example (‘brain banking’) may be associated with greater repugnance than would 
donation of other kinds of tissue. 
 
With respect to future empirically-informed theoretical work, we would argue that such 
research needs from now on to be more focused. Rather than taking an open-ended approach 
and then trying to apply theory to emergent data, it may be better to focus future empirical 
research on specific theoretical questions in specific contexts. This is not intended as a criticism 
of existing empirical research—in a sense what we are seeing in the context of biobanking is an 
emerging topic, the theorisation of which necessarily needs to go through a general, ‘scoping’ 
phase. But if empirically-based sociology is to contribute to more general social theory and to 
the governance of biobanks, it will probably do so best through more focused inquiry. This is 
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particularly important given that there are many areas of disagreement regarding, for example, 
the extent and wisdom of donors’ sense of trust and social solidarity. It has, for example, been 
suggested that there is a need for further research to find out what trust means to people in 
specific contexts and their reasons for trusting one organisation, system or ‘expert’ over 
another (Haddow et al. 2008), and we would support such an approach.  Similar questions 
might be asked about the meanings and effects on specific donor groups of intersubjectivity, 
familial bonds, societal solidarity (e.g. ‘biological citizenship’) and the status of tissue. In this 
way, a more nuanced and contextually-sensitive ‘sociology of biobanking’ might be developed 
which might add, rather than simply refer, to existing sociological theories. Moreover, a more 
nuanced theorisation of donation of biobanks might contribute to our understanding of other 
related social processes such as blood, organ and tissue donation for 
transfusion/transplantation (i.e. therapeutic donation), and participation in other kinds of 
biomedical research. The findings relating to the ambiguous status of tissue might, for example, 
contribute to our understanding of people’s willingness or unwillingness to donate organs and 
tissues for therapeutic purposes, and might point to different ways of motivating donation (e.g. 
by changing the language used, or setting in which people are asked, so as to make people feel 
most comfortable about parting with organs or tissues). Similarly, the findings relating to trust 
might contribute to our understanding of people’s willingess or unwillingess to participate in 
more overtly (physically) risky clinical research.  
 
One question of particular interest would be why it is that many tissue donors are not as 
concerned about biobanking as are many ethicists, lawyers and sociologists. As discussed in the 
introduction, a series of well publicised ‘scandals’ in recent years have led sociologists, lawyers 
and ethicists to examine the relevant social relationships, legal implications and ethical 
principles that may be problematic in the biobanking contexts. These issues have been 
discussed at length, and problems of ownership, confidentiality, relations of power, financial 
returns, perceptions of risk, relevance of information and consent are amongst the many 
matters that figure in the various literatures. At the same time, qualitative research indicates 
that tissue donors do not seem to experience most of these issues as ‘problems’. On the 
contrary, they indicate a high level of trust in the scientists who do the research on their 
tissues; they readily give consent to donate and attach few preconditions; they feel little sense 
of ownership of their donated tissue; they express satisfaction at the potential good that may 
come from their act; they acknowledge, but do not fear, the risk of breaches of confidentiality; 
they generally dismiss fears of commercial exploitation; and they do these things on their own 
behalves and on behalf of family members, including children. Biobanking, in short, seems to be 
working reasonably well, and with the approval of tissue donors. It would therefore be 
worthwhile to try to elucidate systematically what features of the process make it work so well, 
despite the scandals that have prompted scholars and researchers to problematise it. While 
existing qualitative research provides some clues by demonstrating biologically-based social 
solidarity (‘biological citizenship’), high levels of public trust and at least some degree of 
indifference towards tissue itself, we believe that the resilience of tissue banking needs further 
explanation. This might be provided, for example, by considering the various ways in which 
people in different contexts valorise the donation process (if not the tissue itself). While notions 
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of altruism and reciprocity provide a partial explanation, the lack of concern about risk and the 
low level of intentionality associated with the act of donation suggests that an alternative, or at 
least supplementary, explanation might be required.  
 
 
Conclusion 
Qualitative enquiry can provide us with a rich and nuanced picture of the ways in which people 
understand, experience and construct the process of donating tissue to biobanks, and can assist 
us in the ethical management of these important research resources. Existing sociological 
interpretations of qualitative research further enrich this understanding, with reference to a 
large number of social theories. A more contextually-specific and nuanced ‘sociology of 
biobanking’ is, however, needed, and this might be best achieved by exploring specific 
theoretical questions in a variety of biobanking settings. 
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Table 1. Tissue donation to biobanks: a review of sociological studies. 
Study 
number 
and 
reference 
 Details of biobank (note that some biobanks are discussed in 
more than one article) 
 
Details of qualitative study 
 
1 Asai et al. (2002) 
 
Name/organisation: Hypothetical existing tissue archive 
Location: Japan 
Tissue types: Not specified 
Donors: Not specified 
Research focus: Not specified 
Focus groups with  
representatives of potential 
donor (general) population 
 
2 Barr (2006) Name/organisation: The North Cumbria Community Genetics 
Project (NCCGP).  
Location: Northwest England 
Tissue types: Placenta, umbilical cord, blood  
Donors: Pregnant women 
Research focus: Genetic epidemiology 
(e.g. heart disease, cancer and prenatal viability, 
neurodegenerative disease and gene repair of damaged DNA). 
 
Interviews with pregnant 
women who had donated or 
refused to donate 
 
3 Beskow and Dean 
(2008)  
Name/organisation: The Duke Biorepository 
Location: North Carolina, United States 
Tissue types: Leftover blood samples 
Donors: People from the general population who have had 
blood drawn for other reasons 
Research focus: Many diseases including cancer, heart disease, 
diabetes, and other health problems 
 
Interviews with 
representatives of potential 
donor (general) population 
 
4 Busby (2004) Name/organisation: University hospital/ National Health 
Service  
Location: United Kingdom 
Tissue types: Blood 
Donors: People with psoriatic arthritis 
Research focus:  Genetic epidemiology (including rare diseases 
such as psoriatic arthritis) 
 
Interviews with biobank 
participants 
 
5 Dixon-Woods et al. 
(2008)  
Name/organisation: The tumour bank of the UK Childhood 
Cancer and Leukaemia Group (CLLG) 
Location: United Kingdom 
Tissue types: Residual tumour tissue left over after cancer 
diagnosis or therapy 
Donors: Children with cancer 
Research focus: Cancer research 
 
Interviews with children with 
cancer and their parents 
 
6 Ducournau  (2007)  Name/organisation: Biobank associated with the “GENES 
project” 
Location: South of France 
Tissue types: Blood 
Donors: Men from the general population aged 45-75 who are 
recruited specifically for this research 
Research focus: Genetic epidemiology of cardiovascular 
disease 
 
Interviews with 
representatives of potential 
donor (male, age-defined) 
population and ethnographic 
observation of the consent 
process 
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7 Elliot et al. (2008)  Name/organisation: Tumour bank of “SIDS and Kids”  
Location: Australia 
Tissue types: Several tissue types retained at postmortem  
Donors: Children who had died of Sudden Infant Death 
Syndrome 
Research focus: Asthma 
 
Interviews with  parents of 
SIDS infants 
 
8 Godard et al. (2007)  Name/organisation: Quebec CARTaGENE Project 
Location: Quebec, Canada 
Tissue types: Blood 
Donors: Random selection of the general population 
Research focus: Global health issues/ disease risk 
 
Focus groups with  
representatives of potential 
donor (general) population 
 
9 Gustafsson Stolt et 
al. (2002)  
Name/organisation: ABIS (All Babies in Southeast Sweden). 
Location: Sweden 
Tissue types: Blood, hair, milk 
Donors: Neonates and parents from the general population 
Research focus: Childhood diabetes and related diseases 
 
Interviews with participant 
and non-participant mothers 
 
10 Haddow (2009) Name/organisation: Generation Scotland: The Scottish Family 
Health Study’’ 
Location: Scotland 
Tissue types: Blood 
Donors: General population (with a focus on family groups) 
Research focus: genetic contributions to diseases that affect 
the Scottish population e.g., cancer, heart disease and mental 
illness (especially family-based studies) 
 
Interviews with biobank 
participants 
 
11 Haddow et al. 
(2008)  
Name/organisation: Generation Scotland 
Location: Scotland 
Tissue types: Blood 
Donors: General population (and family groups within this to 
facilitate genetic analysis) 
Research focus: Many common diseases 
 
Interviews and focus groups 
with representatives of 
potential donor (general) 
population 
 
12 Haddow et al. 
(2007) 
Name/organisation: Generation Scotland 
Location: Scotland 
Tissue types: Blood 
Donors: General population (and family groups within this to 
facilitate genetic analysis) 
Research focus: Many common diseases 
 
Focus groups with 
representatives of potential 
donor (general) population 
 
13 Haimes & Whong-
Barr (2004)  
Name/organisation: The North Cumbria Community Genetics 
Project (NCCGP).  
Location: Northwest England 
Tissue types: Placenta, umbilical cord, blood  
Donors: Pregnant women 
Research focus: Genetic epidemiology 
(e.g. heart disease, cancer and prenatal viability, 
neurodegenerative disease and gene repair of damaged DNA). 
 
Interviews with participants, 
non-participants and 
representatives of potential 
donor population 
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14 Haimes & Whong-
Barr (2003) 
 
Name/organisation: The North Cumbria Community Genetics 
Project (NCCGP).  
Location: Northwest England 
Tissue types: Placenta, umbilical cord, blood  
Donors: Pregnant women 
Research focus: Genetic epidemiology 
(e.g. heart disease, cancer and prenatal viability, 
neurodegenerative disease and gene repair of damaged DNA). 
 
Interviews with participants, 
non-participants and 
representatives of potential 
donor population 
 
15 Hoeyer (2002)  Name/organisation: UmanGenomics AB 
Type: Population biobank 
Location: Northern Sweden 
Tissue types: Blood 
Donors: General population 
Research focus: Common diseases 
 
Observation and interviews 
with representatives of 
potential donor (general) 
population 
  
16 Hoeyer (2003)  Name/organisation: UmanGenomics AB 
Location: Northern Sweden 
Tissue types: Blood 
Donors: General population 
Research focus: Common diseases 
Observation and interviews 
with representatives of 
potential donor (general) 
population 
 
17 Hoeyer (2004) Name/organisation: UmanGenomics AB 
Location: Northern Sweden 
Tissue types: Blood 
Donors: General population 
Research focus: Common diseases 
Observation and interviews 
with representatives of 
potential donor (general) 
population 
 
18 Hoeyer (2006) Name/organisation: UmanGenomics AB 
Location: Northern Sweden 
Tissue types: Blood 
Donors: General population 
Research focus: Common diseases 
Observation and interviews 
with representatives of 
potential donor (general) 
population 
 
19 Hoeyer & Lynöe 
(2006)  
Name/organisation: UmanGenomics AB 
Location: Northern Sweden 
Tissue types: Blood 
Donors: General population 
Research focus: Common diseases 
Observation and interviews 
with representatives of 
potential donor (general) 
population 
 
20 Jack & Womack 
(2003)  
Name/organisation: Tissue bank of Peterborough Hospitals 
NHS Trust 
Location: United Kingdom 
Tissue types: Surgical 
Donors: Patients undergoing surgery 
Research focus: Commercial/ pharmaceutical research 
 
Interviews with people who 
had refused to donate 
 
21 Kaphingst et al. 
(2006)  
Name/organisation: Dana-Farber Cancer Institute 
Location: United States 
Tissue types: Blood and breast tumour tissue 
Donors:  Female breast cancer patients 
Research focus: Breast cancer 
 
Focus groups and interviews 
with breast cancer patients 
who had consented to 
donation 
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22 Kaufman et al. 
(2008 
Name/organisation: National Institutes of Health and other 
federal agencies  
Location: United States 
Tissue types: Blood, urine, saliva, hair or nail clippings 
Donors: General population (including children) 
Research focus: Many diseases 
Focus groups with 
representatives of potential 
donor (general) population 
 
23 Levitt &Weldon  
(2005)  
Name/organisation: UK biobank 
Location: United Kingdom 
Tissue types: Blood 
Donors: General population 
Research focus: Not specified (many diseases) 
Research focus:  Multiple 
 
Focus groups with 
representatives of potential 
donor (general) population 
  
24 Lipworth et al. 
(2009) 
Name/organisation: Not specified − refers to several tumour 
banks 
Location: Australia 
Tissue types: Residual tumour tissue 
Donors: People with cancer 
Research focus: Cancer research 
 
Interviews with biobank 
participants and other lay 
groups 
 
25 McCarty et al. 
(2008)  
Name/organisation: The Marshfield Clinic 
Personalised Medicine Research Project  
Location: United States 
Tissue types: Blood 
Donors: General population 
Research focus: Genetic epidemiology, pharmacogenetics, and 
population genetics 
 
Focus groups with 
representatives of potential 
donor (general) population 
 
 
26 Murphy et al. 
(2008)  
Name/organisation: A proposed genomic biobank 
Location:  United States 
Tissue types:  Blood  
Donors:  General population 
Research focus:  (Hypothetically) asthma, alzheimer’s disease  
 
Focus groups with 
representatives of potential 
donor (general) population 
 
27 Ormond et al. 
(2009)  
Name/organisation: NUgene Project, Northwestern University 
Location: United States 
Tissue types: Blood 
Donors: General population 
Research focus: Broad range of diseases 
Interviews with  biobank 
participants 
 
28 Richards et al. 
(2003)  
Name/organisation: The Anglican Breast Cancer Study 
Type: Disease-specific blood collection 
Tissue types: Blood 
Donors: Women with breast cancer 
Research focus: Breast cancer genetic epidemiology 
 
Interviews with biobank 
participants 
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29 Rotimi et al. (2007)  Name/organisation: The International HapMap Project 
Type: Population biobank 
Location: International 
Tissue types: Blood 
Donors: General population 
Research focus: Relating genetic variation to health, disease 
and drug response 
 
Interviews and focus groups 
with representatives of each 
research population (in 
Nigeria, Japan, China) 
 
30 Scott et al. (2005)  Name/organisation: Not specified (hypothetical discussions 
about biobanks in general) 
Location: New Zealand 
Tissue types: Not specified 
Donors: General public 
Research focus: Not specified 
Focus groups with 
representatives of potential 
donor (general) population − 
both indigenous and non-
indigenous 
 
31 Secko et al. (2009)  Name/organisation: Hypothetical biobank 
Location: Canada 
Tissue types: Not specified 
Donors: General population 
Research focus: Not specified 
 
Focus groups with  
representatives of potential 
donor (general) population 
 
32 Skolbekken et al. 
(2005)  
Name/organisation: the biobank of the Nord-Trøndelag Health 
Study (HUNT) 
Location: Norway 
Tissue types: Blood 
Donors: General adult population 
Research focus: epidemiological studies, including functional 
genomics 
 
Focus groups with biobank 
participants 
 
33 Sque et al. (2008 Name/organisation: Various NHS Hospital Trusts 
Location: United Kingdom 
Tissue types: Hearts and other organs 
Donors: Children who had died 
Research focus: Not specified (many diseases) 
Interviews and focus groups 
with parents whose children’s 
organs had been retained at 
postmortem examination 
 
34 Traulsen et al. 
(2008) 
Name/organisation: Icelandic Health Sector Database (linked to 
biobanks) 
Location: Iceland 
Tissue types: Blood 
Donors: General population 
Research focus: disease modelling, 
disease management, and genetic linkage of traits and 
outcomes 
 
Focus groups with  
representatives of potential 
donor (general) population 
 
35 Tutton  (2007)  Name/organisation: UK biobank 
Location: United Kingdom 
Tissue types: Blood 
Donors: General population 
Research focus: Not specified (many diseases) 
Focus groups with people with 
experience of human genetic 
research and with 
representatives of potential 
donor (general) populations 
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36 Williamson et al. 
(2004)  
Name/organisation: the Avon Longitudinal Study of Parents 
and Children (ALSPAC)  
Location: United Kingdom (but part of a larger WHO study 
involving seven European countries) 
Tissue types: Maternal blood, maternal urine, cord blood, 
umbilical cord, placenta, hair and nail clippings, teeth, child’s 
blood, DNA and urine. 
Donors: Mothers and children 
Research focus: Genetic epidemiology − including psychiatric 
and behavioural research  (with a longitudinal focus) 
 
Focus groups and interviews 
with parents and children − 
both participants and 
representatives of the eligible 
population 
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